640 related articles for article (PubMed ID: 25284138)
1. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
2. A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients.
Hayes D; Kirkby S; Wehr AM; Lehman AM; McConnell PI; Galantowicz M; Higgins RS; Whitson BA
Transpl Int; 2014 Feb; 27(2):211-8. PubMed ID: 24236829
[TBL] [Abstract][Full Text] [Related]
3. To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival.
Whitson BA; Lehman A; Wehr A; Hayes D; Kirkby S; Pope-Harman A; Kilic A; Higgins RS
Clin Transplant; 2014 Apr; 28(4):450-61. PubMed ID: 24750290
[TBL] [Abstract][Full Text] [Related]
4. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
5. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
6. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
7. Antibody induction therapy for lung transplant recipients.
Penninga L; Møller CH; Penninga EI; Iversen M; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008927. PubMed ID: 24282128
[TBL] [Abstract][Full Text] [Related]
8. Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
Ansari D; Lund LH; Stehlik J; Andersson B; Höglund P; Edwards L; Nilsson J
J Heart Lung Transplant; 2015 Oct; 34(10):1283-91. PubMed ID: 26087667
[TBL] [Abstract][Full Text] [Related]
9. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
11. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
Sureshkumar KK; Hussain SM; Nashar K; Marcus RJ
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):741-9. PubMed ID: 24969182
[TBL] [Abstract][Full Text] [Related]
12. Induction immunosuppression for combined heart-lung transplantation.
Hayes D; McConnell PI; Yates AR; Tobias JD; Galantowicz M; Mansour HM; Tumin D
Clin Transplant; 2016 Oct; 30(10):1332-1339. PubMed ID: 27490992
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
Taber DJ; McGillicuddy JW; Bratton CF; Rohan VS; Nadig S; Dubay D; Baliga PK
Ann Surg; 2017 Sep; 266(3):450-456. PubMed ID: 28654544
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
15. Induction Therapy for Lung Transplantation in COPD: Analysis of the UNOS Registry.
Duffy JS; Tumin D; Pope-Harman A; Whitson BA; Higgins RS; Hayes D
COPD; 2016 Oct; 13(5):647-52. PubMed ID: 26829054
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.
Kirkby S; Whitson BA; Wehr AM; Lehman AM; Higgins RS; Hayes D
J Cyst Fibros; 2015 Jan; 14(1):104-10. PubMed ID: 24948447
[TBL] [Abstract][Full Text] [Related]
17. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
[TBL] [Abstract][Full Text] [Related]
18. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
[TBL] [Abstract][Full Text] [Related]
19. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
Cai J; Terasaki PI
Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
[TBL] [Abstract][Full Text] [Related]
20. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
